The anatomy of first-episode and chronic schizophrenia: An anatomical likelihood estimation meta-analysis

University of Cambridge, Cambridge, England, United Kingdom
American Journal of Psychiatry (Impact Factor: 13.56). 05/2008; 165(8):1015-23. DOI: 10.1176/appi.ajp.2008.07101562
Source: PubMed

ABSTRACT The authors sought to map gray matter changes in first-episode schizophrenia and to compare these with the changes in chronic schizophrenia. They postulated that the data would show a progression of changes from hippocampal deficits in first-episode schizophrenia to include volume reductions in the amygdala and cortical gray matter in chronic schizophrenia.
A systematic search was conducted for voxel-based structural MRI studies of patients with first-episode schizophrenia and chronic schizophrenia in relation to comparison groups. Meta-analyses of the coordinates of gray matter differences were carried out using anatomical likelihood estimation. Maps of gray matter changes were constructed, and subtraction meta-analysis was used to compare them.
A total of 27 articles were identified for inclusion in the meta-analyses. A marked correspondence was observed in regions affected by both first-episode schizophrenia and chronic schizophrenia, including gray matter decreases in the thalamus, the left uncus/amygdala region, the insula bilaterally, and the anterior cingulate. In the comparison of first-episode schizophrenia and chronic schizophrenia, decreases in gray matter volume were detected in first-episode schizophrenia but not in chronic schizophrenia in the caudate head bilaterally; decreases were more widespread in cortical regions in chronic schizophrenia.
Anatomical changes in first-episode schizophrenia broadly coincide with a basal ganglia-thalamocortical circuit. These changes include bilateral reductions in caudate head gray matter, which are absent in chronic schizophrenia. Comparing first-episode schizophrenia and chronic schizophrenia, the authors did not find evidence for the temporolimbic progression of pathology from hippocampus to amygdala, but there was evidence for progression of cortical changes.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Studies that have used structural magnetic resonance imaging (MRI) suggest that individuals with psychoses have brain alterations, particularly in frontal and temporal cortices, and in the white matter tracts that connect them. Furthermore, these studies suggest that brain alterations may be particularly prominent, already at illness onset, in those individuals more likely to have poorer outcomes (eg, higher number of hospital admissions, and poorer symptom remission, level of functioning, and response to the first treatment with antipsychotic drugs). The fact that, even when present, these brain alterations are subtle and distributed in nature, has limited, until now, the utility of MRI in the clinical management of these disorders. More recently, MRI approaches, such as machine learning, have suggested that these neuroanatomical biomarkers can be used for direct clinical benefits. For example, using support vector machine, MRI data obtained at illness onset have been used to predict, with significant accuracy, whether a specific individual is likely to experience a remission of symptoms later on in the course of the illness. Taken together, this evidence suggests that validated, strong neuroanatomical markers could be used not only to inform tailored intervention strategies in a single individual, but also to allow patient stratification in clinical trials for new treatments.
    Dialogues in clinical neuroscience 12/2014; 16(4):491-503.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cognitive insight, measured through one’s ‘‘Self-Reflectiveness’’ and ‘‘Self-Certainty’’, involves the evaluation and correction of distorted beliefs and interpretations, and is important for clinical insight (i.e., awareness of illness) in psychosis. In psychosis, cognitive insight may depend on hippocampal and ventrolateral prefrontal cortical (VLPFC) structure, and verbal memory and executive functions. We explored whether similar relations exist in non-clinical participants. Fifty-one nonclinical subjects completed the Beck Cognitive Insight Scale. Hippocampal volumes and VLPFC thickness were examined using FreeSurfer, and verbal memory and reasoning and problem solving was examined in a subset of the sample (n = 27). Significant correlations emerged between Self-Certainty and left VLPFC thickness, but not Self-Reflectiveness and VLPFC, or either cognitive insight measure and hippocampal volumes. Neither Self-Reflectiveness nor Self-Certainty correlated with neurocognitive functioning. These results provide a framework of mechanisms underlying cognitive insight in non-clinical samples, and allow evaluation of how these process may become dysfunctional in psychosis.
    Cognitive Therapy and Research 03/2015; DOI:10.1007/s10608-015-9674-8 · 1.70 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It is known that there is a high prevalence of certain anxiety disorders among schizophrenic patients, especially panic disorder and social phobia. However, the neural underpinnings of the comorbidity of such anxiety disorders and schizophrenia remain unclear. Our study aims to determine the neuroanatomical basis of the co-occurrence of schizophrenia with panic disorder and social phobia. Voxel-based morphometry was used in order to examine brain structure and to measure between-group differences, comparing magnetic resonance images of 20 anxious patients, 20 schizophrenic patients, 20 schizophrenic patients with comorbid anxiety, and 20 healthy control subjects. Compared to the schizophrenic patients, we observed smaller grey-matter volume (GMV) decreases in the dorsolateral prefrontal cortex and precentral gyrus in the schizophrenic-anxiety group. Additionally, the schizophrenic group showed significantly reduced GMV in the dorsolateral prefrontal cortex, precentral gyrus, orbitofrontal cortex, temporal gyrus and angular/inferior parietal gyrus when compared to the control group. Our findings suggest that the comorbidity of schizophrenia with panic disorder and social phobia might be characterized by specific neuroanatomical and clinical alterations that may be related to maladaptive emotion regulation related to anxiety. Even thought our findings need to be replicated, our study suggests that the identification of neural abnormalities involved in anxiety, schizophrenia and schizophrenia-anxiety may lead to an improved diagnosis and management of these conditions.
    PLoS ONE 10(3):e0119847. DOI:10.1371/journal.pone.0119847 · 3.53 Impact Factor

Full-text (2 Sources)

Available from
May 23, 2014